
SSP-20-006
(SALTKIVA)
NCT04589234
JCP089
A Phase 2 Study of Saltikva (Attenuated Salmonella Typhimurium Containing the Human Gene for Interleukin-2) in Patients With Metastatic Pancreatic Cancer
Status:
Recruiting

II
Phase

1st
Line of Therapy

Advanced / Metastatic
Disease Stage

Biomarker(s)
N/A
Investigational
Product
Saltikva
Attenuated Salmonella Typhimurium containing the gene for human IL-2 (Salmonella-IL2) (p.o.)
Treatment Arms
o Experimental: Saltikva with FOLFIRINOX
o Experimental: Saltikva with Gemcitabine/Abraxane